keyword
https://read.qxmd.com/read/38630893/small-extracellular-vesicles-promote-stiffness-mediated-metastasis
#1
JOURNAL ARTICLE
Alexandra Sneider, Ying Liu, Bartholomew Starich, Wenxuan Du, Praful R Nair, Carolyn Marar, Najwa Faqih, Gabrielle E Ciotti, Joo Ho Kim, Sejal Krishnan, Salma Ibrahim, Muna Igboko, Alexus Locke, Daniel M Lewis, Hanna Hong, Michelle N Karl, Raghav Vij, Gabriella C Russo, Estibaliz Gómez-de-Mariscal, Mehran Habibi, Arrate Muñoz-Barrutia, Luo Gu, T S Karin Eisinger-Mathason, Denis Wirtz
Tissue stiffness is a critical prognostic factor in breast cancer and is associated with metastatic progression. Here we show an alternative and complementary hypothesis of tumor progression whereby physiological matrix stiffness affects the quantity and protein cargo of small EVs produced by cancer cells, which in turn aid cancer cell dissemination. Primary patient breast tissue produces significantly more EVs from stiff tumor tissue than soft tumor adjacent tissue. EVs released by cancer cells on matrices that model human breast tumors (25 kPa; stiff EVs) feature increased adhesion molecule presentation (ITGα2β1, ITGα6β4, ITGα6β1, CD44) compared to EVs from softer normal tissue (0...
April 17, 2024: Cancer Res Commun
https://read.qxmd.com/read/38630886/lp-184-a-novel-acylfulvene-molecule-exhibits-anti-cancer-activity-against-diverse-solid-tumors-with-homologous-recombination-deficiency
#2
JOURNAL ARTICLE
Aditya Kulkarni, Jianli Zhou, Neha Biyani, Umesh Kathad, Partha P Banerjee, Shiv Srivastava, Zsombor Prucsi, Kamil Solarczyk, Kishor Bhatia, Reginald B Ewesuedo, Panna Sharma
Homologous recombination (HR) related gene alterations are present in a significant subset of prostate, breast, ovarian, pancreatic, lung and colon cancers rendering these tumors as potential responders to specific DNA damaging agents. A small molecule acylfulvene prodrug, LP-184, metabolizes to an active compound by the oxidoreductase activity of enzyme Prostaglandin Reductase 1 (PTGR1), which is frequently elevated in multiple solid tumor types. Prior work demonstrated that cancer cell lines deficient in a spectrum of (DNA damage repair) DDR pathway genes show increased susceptibility to LP-184...
April 17, 2024: Cancer Res Commun
https://read.qxmd.com/read/38630860/design-of-dry-powder-inhalers-to-improve-patient-outcomes-it-s-not-just-about-the-device
#3
REVIEW
Jeffry G Weers
INTRODUCTION: Up to 50% of asthma/COPD patients make critical errors in dose preparation and dose inhalation with current marketed DPIs which negatively impact clinical outcomes. Others fail to adhere to their chronic treatment regimen. AREAS COVERED: For this review, we describe how a human-factors approach to design of a dry powder inhaler can be used to improve usability, proficiency, and functionality of DPIs, while effectively mitigating critical errors associated with DPIs...
April 17, 2024: Expert Opinion on Drug Delivery
https://read.qxmd.com/read/38630555/overcoming-osimertinib-resistance-with-akt-inhibition-in-egfrm-driven-non-small-cell-lung-cancer-with-pik3ca-pten-alterations
#4
JOURNAL ARTICLE
Ursula Grazini, Aleksandra Markovets, Lucy Ireland, Daniel O'Neill, Benjamin Phillips, Man Xu, Matthias Pfeifer, Tereza Vaclova, Matthew J Martin, Ludovic Bigot, Luc Friboulet, Ryan Hartmaier, Maria Emanuela Cuomo, Simon T Barry, Paul D Smith, Nicolas Floc'h
PURPOSE: Osimertinib is an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) indicated for the treatment of EGFR mutated (EGFRm)-driven lung adenocarcinomas. Osimertinib significantly improves progression-free survival in first-line treated patients with EGFRm advanced NSCLC. Despite the durable disease control, the majority of patients receiving osimertinib eventually develop disease progression. EXPERIMENTAL DESIGN: ctDNA profiling analysis on-progression plasma samples from patients treated with osimertinib in both first (Phase 3, FLAURA trial) and second-line trials (Phase 3, AURA3 trial) revealed a high prevalence of PIK3CA/AKT/PTEN alterations...
April 17, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38630364/sirtuins-and-cellular-senescence-in-patients-with-idiopathic-pulmonary-fibrosis-and-systemic-autoimmune-disorders
#5
REVIEW
Vito D'Agnano, Domenica Francesca Mariniello, Raffaella Pagliaro, Mehrdad Savabi Far, Angela Schiattarella, Filippo Scialò, Giulia Stella, Maria Gabriella Matera, Mario Cazzola, Andrea Bianco, Fabio Perrotta
The sirtuin family is a heterogeneous group of proteins that play a critical role in many cellular activities. Several degenerative diseases have recently been linked to aberrant sirtuin expression and activity because of the involvement of sirtuins in maintaining cell longevity and their putative antiaging function. Idiopathic pulmonary fibrosis and progressive pulmonary fibrosis associated with systemic autoimmune disorders are severe diseases characterized by premature and accelerated exhaustion and failure of alveolar type II cells combined with aberrant activation of fibroblast proliferative pathways leading to dramatic destruction of lung architecture...
April 17, 2024: Drugs
https://read.qxmd.com/read/38630325/chlordiazepoxide-against-signalling-receptor-and-regulatory-proteins-of-breast-cancer-a-structure-based-in-silico-approach
#6
JOURNAL ARTICLE
Ahad Amer Alsaiari, Amal F Gharib, Maha Mahfouz Bakhuraysah, Amani A Alrehaili, Shatha M Algethami, Hayfa Ali Alsaif, Norah Al Harthi, Mohammed Ageeli Hakami
Among the most prevalent forms of cancer are breast, lung, colon-rectum, and prostate cancers, and breast cancer is a major global health challenge, contributing to 2.26 million cases with approximately 685,000 deaths worldwide in 2020 alone, typically beginning in the milk ducts or lobules that produce and transport milk during lactation and it is becoming challenging to treat as the tissues are developing resistance, which makes urgent calls for new multitargeted drugs. The multitargeted drug design provides a better solution, simultaneously targeting multiple pathways, even when the drug resists one, it remains effective for others...
April 17, 2024: Medical Oncology
https://read.qxmd.com/read/38629624/single-cell-transcriptomics-reveal-metastatic-cldn4-cancer-cells-underlying-the-recurrence-of-malignant-pleural-effusion-in-patients-with-advanced-non-small-cell-lung-cancer
#7
JOURNAL ARTICLE
Xiaoshen Zhang, Xuanhe Wang, Yaokai Wen, Shen Chen, Caicun Zhou, Fengying Wu
BACKGROUND: Recurrent malignant pleural effusion (MPE) resulting from non-small-cell lung cancer (NSCLC) is easily refractory to conventional therapeutics and lacks predictive markers. The cellular or genetic signatures of recurrent MPE still remain largely uncertain. METHODS: 16 NSCLC patients with pleural effusions were recruited, followed by corresponding treatments based on primary tumours. Non-recurrent or recurrent MPE was determined after 3-6 weeks of treatments...
April 2024: Clinical and Translational Medicine
https://read.qxmd.com/read/38629432/post-tuberculosis-respiratory-impairment-in-gambian-children-and-adolescents-a-cross-sectional-analysis
#8
JOURNAL ARTICLE
Esin Nkereuwem, Schadrac Agbla, Bintou Njai, Victory Fabian Edem, Muhammed Lamin Jatta, Olumuyiwa Owolabi, Uma Masterton, Fatoumatta Jah, Madikoi Danso, Aunty Nyima Fofana, Wandifa Samateh, Muhammed Lamin Darboe, Sheila Ageiwaa Owusu, Andrew Bush, Beate Kampmann, Toyin Togun
BACKGROUND: Although post-tuberculosis lung disease (PTLD) is a known consequence of pulmonary tuberculosis (pTB), few studies have reported the prevalence and spectrum of PTLD in children and adolescents. METHODS: Children and adolescent (≤19 years) survivors of pTB in the Western Regions of The Gambia underwent a respiratory symptom screening, chest X-ray (CXR) and spirometry at TB treatment completion. Variables associated with lung function impairment were identified through logistic regression models...
April 17, 2024: Pediatric Pulmonology
https://read.qxmd.com/read/38629430/cystic-fibrosis-in-iceland-and-the-high-prevalence-of-the-n1303k-variant
#9
JOURNAL ARTICLE
Helga Elidottir, Selma R Bjarnadottir, Olafur Baldursson, Brynja Jonsdottir
BACKGROUND: Cystic fibrosis (CF) is most common in populations of Northern European ancestry where the F508del variant predominates. In 2020, Iceland became a member of the European Cystic Fibrosis Society Patient Registry, and we launched an epidemiological study of CF in Iceland. The study aimed to determine the prevalence and the genetic variants present in the country. Furthermore, we aimed to describe the previous and the current situation regarding lung function, infections, complications, treatment, and follow-up to understand the strengths and weaknesses of CF care in Iceland...
April 17, 2024: Pediatric Pulmonology
https://read.qxmd.com/read/38628706/assessment-of-lung-function-variability-documents-airflow-limitation-in-many-patients-with-long-covid
#10
Tonje Reier-Nilsen, Charlotte Grønneberg, Stephanie Røine, Björn Nordlund
BACKGROUND: It is estimated that 65 million people worldwide suffer from long covid (LC). Many LC symptoms are also reported by patients with airflow limitation, used to confirm asthma. The primary aim was to detect airflow limitation in LC patients by a methacholine bronchial provocation test (BPT) and if negative, by evaluation of diurnal variability in forced expiratory flow in 1 second (FEV1 ) over a two-weeks' period. The second aim was to assess responsiveness to asthma treatment on diurnal FEV1 variability and LC symptoms...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38628667/uniportal-video-assisted-thoracoscopic-segmentectomy-for-fetal-adenocarcinoma-lung-cancer-with-severe-pulmonary-emphysema-a-case-report
#11
Yun-Sheng Wu, Yu-Ting Chen, Jen-Hao Chuang, Hsien-Chi Liao
BACKGROUND: Fetal adenocarcinoma is a very rare subtype of lung adenocarcinoma. Its incidence ranges from 0.1 to 0.87% among all primary lung neoplasms. Low-grade types tend to appear in the younger generation, and the age ranges from 20 to 50 years with a mean age of around 35 years. Surgical resection is currently the best way to treat fetal adenocarcinoma lung cancer without distant metastasis. CASE REPORT: This is a 56-year-old female who underwent low-dose computer tomography (LDCT) screening during the health examination...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38628656/deep-lymph-node-enlargement-and-renal-failure-caused-by-hypercalcemia%C3%A2-associated-sarcoidosis-a-case-report
#12
Zezhou Liu, Zhigang Tang, Jingping Yuan, Ke Su, Yonghong Jian, Hongyan Liu
Sarcoidosis is a rare disease that severely affects the lungs and superficial lymph nodes. In addition, this disease can also affect the skin, eyes and kidneys to varying degrees. The present report described a 32-year-old male patient who was admitted to Renmin Hospital of Wuhan University (Wuhan, China) due to joint pain in the extremities. He was diagnosed with uncorrectable hypercalcemia. A lymph node biopsy revealed the hypercalcemia to be associated with sarcoidosis, with the patient also demonstrating renal failure and lymph node enlargement...
May 2024: Experimental and Therapeutic Medicine
https://read.qxmd.com/read/38627776/the-value-of-lung-function-assessment-and-testin-expression-detection-in-clinicopathological-features-and-prognosis-of-nsclc-patients
#13
JOURNAL ARTICLE
Yanmin Zhang, Gaoming Wang, Qian Zhang, Qian Wang, Jing Luo, Chunhua Ling
OBJECTIVE: The aim of this study is to investigate the clinical value and potential prognostic significance of lung function assessment and Testin expression in non-small cell lung cancer (NSCLC) patients. METHODS: The NSCLC patients were classified into three groups according to lung function: group of normal lung function, group of PRISm (preserved ratio impaired spirometry) (FEV1, forced expiratory volume during the first second < 80% predicted and FEV1/FVC (forced vital capacity) ≥ 70%) and group of COPD (chronic obstructive pulmonary disease) (FEV1/FVC < 70%)...
April 16, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38627774/expression-of-lncrna-linc00943-in-lung-squamous-cell-carcinoma-and-its-relationship-with-tumor-progression
#14
JOURNAL ARTICLE
Zhenshan Zhao, Haiyang Li, Jing Li, Yao Rong, Lidong Zhao, Menghui Hao, Faming Tian
BACKGROUND: Molecular biology has been applied to the diagnosis, prognosis and treatment of various diseases, and long noncoding RNA LINC00943 (lncRNA LINC00943; LINC00943) plays an important role in a variety of cancers. Therefore, this study explored the prognostic role of LINC00943 in lung squamous cell carcinoma (LUSC) and understood its impact on the development of LUSC. METHODS: There are 89 LUSC patients were involved in current assay. By detecting the expression of LINC00943 and miR-196b-5p in tissues and cells, LINC00943 and its correlation with the characteristics of clinical data were analyzed...
April 16, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38627696/decreased-serpin-c1-in-extracellular-vesicles-predicts-response-to-methotrexate-treatment-in-patients-with-pulmonary-sarcoidosis
#15
JOURNAL ARTICLE
Raisa Kraaijvanger, Montse Janssen Bonás, Jan C Grutters, Ioanna Paspali, Marcel Veltkamp, Dominique P V de Kleijn, Coline H M van Moorsel
BACKGROUND: Sarcoidosis is a systemic granulomatous disease of unknown etiology primarily affecting the lungs. Treatment is needed when disease symptoms worsen and organ function deteriorates. In pulmonary sarcoidosis, prednisone and methotrexate (MTX) are the most common anti-inflammatory therapies. However, there is large inter-patient variability in response to treatment, and predictive response markers are currently lacking. OBJECTIVE: In this study, we investigated the predictive potential of biomarkers in extracellular vesicles (EVs) isolated from biobanked serum of patients with pulmonary sarcoidosis stored prior to start of therapy...
April 16, 2024: Respiratory Research
https://read.qxmd.com/read/38627519/co-clustering-of-ephb6-and-ephrinb1-in-trans-restrains-cancer-cell-invasion
#16
JOURNAL ARTICLE
Lung-Yu Liang, Niall D Geoghegan, Michael Mlodzianoski, Andrew Leis, Lachlan W Whitehead, Minglyanna G Surudoi, Samuel N Young, Peter Janes, Doulin Shepherd, Debnath Ghosal, Kelly L Rogers, James M Murphy, Isabelle S Lucet
EphB6 is an understudied ephrin receptor tyrosine pseudokinase that is downregulated in multiple types of metastatic cancers. Unlike its kinase-active counterparts which autophosphorylate and transmit signals upon intercellular interaction, little is known about how EphB6 functions in the absence of intrinsic kinase activity. Here, we unveil a molecular mechanism of cell-cell interaction driven by EphB6. We identify ephrinB1 as a cognate ligand of EphB6 and show that in trans interaction of EphB6 with ephrinB1 on neighboring cells leads to the formation of large co-clusters at the plasma membrane...
April 16, 2024: Communications Biology
https://read.qxmd.com/read/38627338/the-core-syndrome-an-overlap-of-severe-asthma-obstructive-sleep-apnea-rhinosinusitis-and-esophageal-reflux
#17
JOURNAL ARTICLE
Pasquale Tondo, Anela Hoxhallari, Donato Lacedonia, Pietro Magaletti, Roberto Sabato, Maria Pia Foschino Barbaro, Giulia Scioscia
PURPOSE: Asthma, obstructive sleep apnea (OSA), rhinosinusitis, and esophageal reflux are conditions that may overlap, forming a syndrome known as CORE. Whenever clinical remission of severe asthma (SA) is not achieved, it is essential to investigate the presence of comorbidities, in particular the presence of OSA that may lead to the diagnosis of CORE syndrome. METHODS: The study was conducted on naive patients with SA and concomitant rhinosinusitis and esophageal reflux, referred to our institute since 2018...
April 16, 2024: Sleep & Breathing
https://read.qxmd.com/read/38627317/efficacy-and-safety-analysis-of-immunotherapy-in-non-small-cell-lung-cancer-patients-with-met-alterations
#18
JOURNAL ARTICLE
Yanhua Wang, Jingwen Wei, Manyi Xu, Jing Xiang, Keda Shao, Yue Hao, Zhengbo Song
BACKGROUND: Mesenchymal epithelial transition factor (MET) is a rare oncologic driver gene, and information on immunotherapy for non-small cell lung cancer (NSCLC) patients with this driver gene is limited. Here we evaluate the efficacy and safety of immune checkpoint inhibitors (ICI) under different therapeutic regimen for NSCLC patients with MET alterations. METHODS: From June 2019 to December 2023, we assessed the efficacy and toxicity of ICIs in 42 NSCLC patients with MET alterations...
April 16, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/38627132/classifying-future-healthcare-utilization-in-copd-using-quantitative-ct-lung-imaging-and-two-step-feature-selection-via-sparse-subspace-learning-with-the-cancold-study
#19
JOURNAL ARTICLE
Amir Moslemi, Cameron J Hague, James C Hogg, Jean Bourbeau, Wan C Tan, Miranda Kirby
RATIONALE: Although numerous candidate features exist for predicting risk of higher risk of healthcare utilization in patients with chronic obstructive pulmonary disease (COPD), the process for selecting the most discriminative features remains unclear. OBJECTIVE: The objective of this study was to develop a robust feature selection method to identify the most discriminative candidate features for predicting healthcare utilization in COPD, and compare the model performance with other common feature selection methods...
April 15, 2024: Academic Radiology
https://read.qxmd.com/read/38626545/reniformin-a-suppresses-non-small-cell-lung-cancer-progression-by-inducing-tlr4-nlrp3-caspase-1-gsdmd-dependent-pyroptosis
#20
JOURNAL ARTICLE
Huiyu Zhu, Yifei Guan, Wei Wang, Xinhui Liu, Sijia Wang, Ran Zheng, Yihan Li, Lei Liu, Hua Huang
Pyroptosis is an inflammatory form of programmed cell death that plays an important role in regulating tumor progression. Reniformin A (RA) is a natural compound isolated from the medicinal herb Isodon excisoides that has been applied as folk medicine in the treatment of esophageal cancer. However, whether RA has an individual function in cancer and the molecular mechanisms remain unclear. Here, we show that in non-small-cell lung cancer (NSCLC), RA inhibits tumor growth by functioning as a pyroptosis inducer to promote TLR4/NLRP3/caspase-1/GSDMD axis...
April 15, 2024: International Immunopharmacology
keyword
keyword
9166
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.